Laparoscopic and endoscopic surgery for early stomach cancer
Part of Cancer, Digestive system clinical trials.
This study tests a less invasive surgery for early stomach cancer that combines a camera in the belly with a scope down the throat. It aims to remove the cancer while saving as much of the stomach as possible, which may mean a quicker recovery and better quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a single early stomach cancer confirmed by biopsy.
- The cancer is confined to the top layer of the stomach wall, with no spread to lymph nodes or other organs.
- You are not a good candidate for endoscopic removal alone (e.g., the lesion is too large, scarred, or difficult to remove that way).
- The cancer is no larger than 5 cm across.
- You are in good general health (able to perform daily activities) and can tolerate anesthesia and surgery.
- You understand the risks and benefits, including the small chance the cancer may have spread and you may need a more standard surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two surgical techniques for early-stage stomach cancer. It aims to remove the tumor and check nearby lymph nodes more precisely, which may help guide treatment and reduce side effects.
This trial is testing a combined approach using two types of endoscopy (a tube with a camera) along with minimally invasive surgery to treat early-stage stomach cancer. The goal is to remove the cancer with less impact on your body compared to standard surgery.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
This study looks at a surgical technique (“dual-port laparoscopic distal gastrectomy”) for people with stomach adenocarcinoma at an early, specific stage. The goal is to remove the tumor with clean margins (called an “R0” result) and see how this approach works safely.
This trial compares two ways to treat early stomach cancer: removing it through an endoscope versus doing an operation. It’s meant for a specific stomach-cancer type (undifferentiated) that has not spread, to see which approach may be better.
This trial tests whether a minimally invasive camera-guided surgical procedure (laparoscopy) can better detect hidden cancer spread in patients with advanced stomach cancer. The goal is to help doctors plan the best treatment and improve outcomes.
Hear when a new Early-stage Upper Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.